Treatment of acute ischemic stroke: beyond thrombolysis and supportive care
- PMID: 21556680
- PMCID: PMC3250267
- DOI: 10.1007/s13311-011-0041-5
Treatment of acute ischemic stroke: beyond thrombolysis and supportive care
Abstract
The initial therapeutic approach to acute ischemic stroke consists of thrombolytic therapy and early initiation of supportive care, usually commenced prior to the determination of the underlying stroke etiology. Varying stroke mechanisms may call for specific, etiology-based treatment. The majority of strokes result from cardioembolism, large-vessel atherothromboembolism, and small-vessel occlusive disease. There are scant data to support the use of acute anticoagulation therapy over anti-platelet therapy in cardioembolic stroke and large-vessel atherosclerosis, although it may be reasonable in a certain subset of patients. However, augmentation of blood flow with early surgery, stenting, or induced hypertension, may play a role in patients with large artery stenosis. The less commonly identified stroke mechanisms may warrant special consideration in treatment. Controversy remains regarding the optimal anti-thrombotic treatment of arterial dissection. Reversible cerebral vasoconstriction syndrome may benefit from therapy with calcium channel blockers, high-dose steroids, or magnesium, although spontaneous recovery may occur. Inflammatory vasculopathies, such as isolated angiitis of the central nervous system and temporal arteritis, require prompt diagnosis as the mainstay of therapy is immunosuppression. Cerebral venous thrombosis is a rare cause of stroke, but one that needs early identification and treatment with anticoagulation. Rapid determination of stroke mechanism is essential for making these critical early treatment decisions.
Figures




Similar articles
-
[Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].Rev Neurol (Paris). 2012 Jun;168(6-7):512-21. doi: 10.1016/j.neurol.2012.01.587. Epub 2012 May 28. Rev Neurol (Paris). 2012. PMID: 22647807 Review. French.
-
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717
-
Endovascular Treatment of Thrombosis and Embolism.Adv Exp Med Biol. 2017;906:195-213. doi: 10.1007/5584_2016_116. Adv Exp Med Biol. 2017. PMID: 27664152 Review.
-
Development of a carotid artery thrombolysis stroke model in mice.Blood Adv. 2022 Sep 27;6(18):5449-5462. doi: 10.1182/bloodadvances.2021006008. Blood Adv. 2022. PMID: 35767737 Free PMC article.
-
Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis.J Thromb Thrombolysis. 2017 Jan;43(1):86-90. doi: 10.1007/s11239-016-1404-x. J Thromb Thrombolysis. 2017. PMID: 27469539
Cited by
-
Heads Up! A Novel Provocative Maneuver to Guide Acute Ischemic Stroke Management.Interv Neurol. 2017 Mar;6(1-2):8-15. doi: 10.1159/000449322. Epub 2016 Sep 30. Interv Neurol. 2017. PMID: 28611828 Free PMC article.
-
Safety and outcomes of intravenous thrombolysis in dissection-related ischemic stroke: an international multicenter study and comprehensive meta-analysis of reported case series.J Neurol. 2015 Sep;262(9):2135-43. doi: 10.1007/s00415-015-7829-x. Epub 2015 Jun 25. J Neurol. 2015. PMID: 26108410
-
The Sphkl/SlP pathway regulates angiogenesis via NOS/NO synthesis following cerebral ischemia-reperfusion.CNS Neurosci Ther. 2020 May;26(5):538-548. doi: 10.1111/cns.13275. Epub 2019 Dec 8. CNS Neurosci Ther. 2020. PMID: 31814336 Free PMC article.
-
Versatile strategies for adult neurogenesis: avenues to repair the injured brain.Neural Regen Res. 2024 Apr;19(4):774-780. doi: 10.4103/1673-5374.382224. Neural Regen Res. 2024. PMID: 37843211 Free PMC article. Review.
-
Pipoxolan ameliorates cerebral ischemia via inhibition of neuronal apoptosis and intimal hyperplasia through attenuation of VSMC migration and modulation of matrix metalloproteinase-2/9 and Ras/MEK/ERK signaling pathways.PLoS One. 2013 Sep 24;8(9):e75654. doi: 10.1371/journal.pone.0075654. eCollection 2013. PLoS One. 2013. PMID: 24086601 Free PMC article.
References
-
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997;349:1569–1581. - PubMed
-
- Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group. Stroke 1983;14:668–676. - PubMed
-
- Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet. 2000;355:1205–1210. doi: 10.1016/S0140-6736(00)02085-7. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous